Opinion
13 CIVIL 3700 (KMW)
09-14-2022
UNITED STATES OF AMERICA; the States of CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, FLORIDA, GEORGIA, HAWAII, ILLINOIS, INDIANA, IOWA, LOUISIANA, MASSACHUSETTS, MICHIGAN, MINNESOTA, MONTANA, NEVADA, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, OKLAHOMA, RHODE ISLAND, TENNESSEE, TEXAS, VIRGINIA, WASHINGTON and WISCONSIN, the DISTRICT OF COLUMBIA, THE CITY OF CHICAGO and THE CITY OF NEW YORK ex rel. STEVEN M. CAMBURN, Plaintiffs and Relator, v. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant.
JUDGMENT
It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Opinion and Order dated September 13, 2022, Novartis' motion to dismiss pursuant to Rules 12(b)(6) and 9(b) is GRANTED, and the TAC is dismissed with prejudice; accordingly, the case is closed.